Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Polymarket and Kalshi have extended their invite and promo codes through July — $70 to trade on Polymarket, $20 on Kalshi — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results